Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

844 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of adenomatous polyposis in a fecal immunochemical test-based colorectal cancer screening program and risk of advanced neoplasia during follow-up.
Carballal S, Sánchez A, Moreira L, Cuellar-Monterrubio JE, Bernuy J, Daca M, Ortiz O, Ocaña T, Rivero-Sánchez L, Jung G, Serradesanferm A, Pozo A, Grau J, Torá I, Zaffalon D, Castells A, Pellisé M, Balaguer F; PROCOLON Group. Carballal S, et al. Among authors: grau j. Endoscopy. 2022 Jul;54(7):688-697. doi: 10.1055/a-1660-5353. Epub 2021 Dec 21. Endoscopy. 2022. PMID: 34607378 Free article.
Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.
Auge JM, Pellise M, Escudero JM, Hernandez C, Andreu M, Grau J, Buron A, López-Cerón M, Bessa X, Serradesanferm A, Piracés M, Macià F, Guayta R, Filella X, Molina R, Jimenez W, Castells A; PROCOLON Group. Auge JM, et al. Among authors: grau j. Gastroenterology. 2014 Sep;147(3):628-636.e1. doi: 10.1053/j.gastro.2014.06.008. Epub 2014 Jun 14. Gastroenterology. 2014. PMID: 24937264
Reassessment colonoscopy to diagnose serrated polyposis syndrome in a colorectal cancer screening population.
Rivero-Sanchez L, Lopez-Ceron M, Carballal S, Moreira L, Bessa X, Serradesanferm A, Pozo A, Augé JM, Ocaña T, Sánchez A, Leoz ML, Cuatrecasas M, Grau J, Llach J, Castells A, Balaguer F, Pellisé M; Procolon Group. Rivero-Sanchez L, et al. Among authors: grau j. Endoscopy. 2017 Jan;49(1):44-53. doi: 10.1055/s-0042-115640. Epub 2016 Oct 14. Endoscopy. 2017. PMID: 27741536
Evaluating the Potential of Polygenic Risk Score to Improve Colorectal Cancer Screening.
Arnau-Collell C, Díez-Villanueva A, Bellosillo B, Augé JM, Muñoz J, Guinó E, Moreira L, Serradesanferm A, Pozo À, Torà-Rocamora I, Bonjoch L, Ibañez-Sanz G, Obon-Santacana M, Moratalla-Navarro F, Sanz-Pamplona R, Márquez Márquez C, Rueda Miret R, Pérez Berbegal R, Piquer Velasco G, Hernández Rodríguez C, Grau J, Castells A, Borràs JM, Bessa X, Moreno V, Castellví-Bel S. Arnau-Collell C, et al. Among authors: grau j. Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1305-1312. doi: 10.1158/1055-9965.EPI-22-0042. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35511747 Free PMC article.
Colorectal cancer after negative colonoscopy in fecal immunochemical test-positive participants from a colorectal cancer screening program.
Rivero-Sánchez L, Grau J, Augé JM, Moreno L, Pozo A, Serradesanferm A, Díaz M, Carballal S, Sánchez A, Moreira L, Balaguer F, Pellisé M, Castells A; PROCOLON group. Rivero-Sánchez L, et al. Among authors: grau j. Endosc Int Open. 2018 Sep;6(9):E1140-E1148. doi: 10.1055/a-0650-4296. Epub 2018 Sep 11. Endosc Int Open. 2018. PMID: 30211305 Free PMC article.
Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program.
Buron A, Román M, Augé JM, Macià F, Grau J, Sala M, Louro J, Martinez-Alonso M, Alvarez-Urturi C, Andreu M, Bessa X, Zaffalon D, Castells A, Pellisé M, Aldea M, Rivero L, Hernández C, Torá-Rocamora I, Castells X. Buron A, et al. Among authors: grau j. Eur J Cancer. 2019 Jan;107:53-59. doi: 10.1016/j.ejca.2018.11.004. Epub 2018 Dec 10. Eur J Cancer. 2019. PMID: 30544059
Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal Cancer.
Duran-Sanchon S, Moreno L, Gómez-Matas J, Augé JM, Serra-Burriel M, Cuatrecasas M, Moreira L, Serradesanferm A, Pozo À, Grau J, Pellisé M, Gironella M, Castells A. Duran-Sanchon S, et al. Among authors: grau j. Clin Gastroenterol Hepatol. 2021 Feb;19(2):323-330.e1. doi: 10.1016/j.cgh.2020.02.043. Epub 2020 Feb 28. Clin Gastroenterol Hepatol. 2021. PMID: 32113893 Free article.
Ascorbic acid PEG-2L is superior for early morning colonoscopies in colorectal cancer screening programs: a prospective non-randomized controlled trial.
Rodríguez de Miguel C, Serradesanferm A, López-Cerón M, Carballal S, Pozo A, Balaguer F, Cárdenas A, Fernández-Esparrach G, Ginés A, González-Suárez B, Moreira L, Ordás I, Ricart E, Sendino O, Vaquero EC, Ubré M, del Manzano S, Grau J, Llach J, Castells A, Pellisé M; PROCOLON group. Rodríguez de Miguel C, et al. Among authors: grau j. Gastroenterol Hepatol. 2015 Feb;38(2):62-70. doi: 10.1016/j.gastrohep.2014.09.007. Epub 2014 Oct 29. Gastroenterol Hepatol. 2015. PMID: 25458542 Clinical Trial.
844 results